![Mark Leuchtenberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Leuchtenberger
Président chez
NEUROSENSE THERAPEUTICS LTD.
Fortune : 267 606 $ au 31/05/2026
Profil
Mark Wayne Leuchtenberger was the founder of Mercator Therapeutics, Inc. (2009), holding the title of Director from 2009 to 2012.
Mr. Leuchtenberger is also the founder of Albor Biologics, Inc., Alvos Therapeutics, Inc. Mr. Leuchtenberger is currently the Chief Executive Officer at Spybiotech Ltd. since 2022, the Chairman at Neurosense Therapeutics Ltd. since 2021, and the Director at Wake Forest University.
Former positions include Chairman, President & Chief Executive Officer at Acusphere, Inc. from 2013 to 2015, President, Chief Executive Officer & Director at Chiasma, Inc. from 2015 to 2016, President & Chief Executive Officer at Targanta Therapeutics Corp.
from 2006 to 2009, President, Chief Executive Officer & Director at Melinta Subsidiary Corp.
from 2011 to 2013, President & Chief Executive Officer at Therion Biologics Corp.
from 2002 to 2006, President & Chief Executive Officer at Eterna Therapeutics LLC from 2018 to 2019, Chief Executive Officer at Ernexa Therapeutics, Inc. from 2017 to 2019, President, Chief Executive Officer & Director at IRX Therapeutics, Inc. from 2017 to 2019, Non-Executive Chairman at Xenetic Biosciences, Inc. from 2014 to 2015, Executive Chairman at Aleta Biotherapeutics, Inc., Director at EPIX Pharmaceuticals, Inc., Director at NeuroHealing Pharmaceuticals, Inc., Director at Beth Israel Deaconess Medical Center, Inc., and Director at Massachusetts Biotechnology Council.
Education includes an undergraduate degree from Wake Forest University and an MBA from Yale School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2026 | 325 951 ( 0,92% ) | 267 606 $ | 31/05/2026 |
Postes actifs de Mark Leuchtenberger
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Président | 01/10/2021 |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Develops a molecular superglue which it believes can be used to create vaccines | Directeur Général | 12/07/2022 |
Anciens postes connus de Mark Leuchtenberger
| Sociétés | Poste | Fin |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Directeur Général | 01/12/2019 |
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Directeur Général | 01/12/2019 |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Directeur Général | 01/12/2019 |
| CHIASMA, INC. | Directeur Général | 01/10/2016 |
| XENETIC BIOSCIENCES, INC. | Président | 16/04/2015 |
Formation de Mark Leuchtenberger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Acusphere, Inc.
 Acusphere, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Mercator Therapeutics, Inc.
 Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Health Technology |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Therion Biologics Corp.
 Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for cancer patients | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
NeuroHealing Pharmaceuticals, Inc.
 NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapies for the post-acute and chronic neuro-rehabilitation patients | Health Technology |
Albor Biologics, Inc. | |
Alvos Therapeutics, Inc.
 Alvos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Health Technology |
Yale School of Management
 Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Develops a molecular superglue which it believes can be used to create vaccines | Health Technology |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Commercial Services |
Neurosense Therapeutics Ltd.
 Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Eterna Therapeutics, Inc.
 Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
